This inventor holds 1 USPTO granted patent. Top assignee: Jinan University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Evandro Fei Fang: Innovator in Neurodegenerative Disease Treatment
Evandro Fei Fang is a prominent inventor based in Shanghai, CN. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. His innovative approach focuses on the use of natural compounds to promote cellular health and mitigate the effects of debilitating conditions.
Latest Patents
Evandro Fei Fang holds a patent for the "Use of Crassifolin A in preparation of drug for promoting mitophagy and treating neurodegenerative diseases." This invention discloses the potential of Crassifolin A, a diterpene compound, to significantly enhance mitophagy levels. The compound promotes the removal of damaged mitochondria, thereby maintaining cellular homeostasis. Furthermore, Crassifolin A can easily penetrate the blood-brain barrier, making it a promising candidate for treating neurodegenerative diseases. The compound is derived from the Thickleaf croton root, which offers abundant medicinal sources, low toxicity, and minimal side effects, indicating a favorable application prospect in medical treatments.
Career Highlights
Evandro Fei Fang is affiliated with Jinan University, where he continues to advance his research and innovation in the field of neurodegenerative diseases. His work emphasizes the importance of utilizing natural compounds in drug development, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Evandro has collaborated with notable colleagues, including Yubo Zhang and Fei Xiao. Their combined expertise contributes to the advancement of research in the field, fostering a collaborative environment that encourages innovation and discovery.
Conclusion
Evandro Fei Fang's contributions to the field of medicine, particularly through his patent on Crassifolin A, highlight the potential of natural compounds in treating neurodegenerative diseases. His work at Jinan University and collaborations with fellow researchers underscore his dedication to advancing medical science. The future of neurodegenerative disease treatment looks promising with innovators like Evandro leading the way.